Your morning coffee could one day help fight cancer
Researchers at Texas A&M developed a chemogenetic system that links caffeine sensing to CRISPR-based editing, enabling on-demand activation of gene editing in targeted cells, including immune T cells.
Why it mattersTexas A&M researchers linked caffeine sensing to CRISPR, enabling on-demand T cell editing and safer targeted cancer immunotherapy.